Marte Lie H.
- Country
- Norway
- Department
- Gastromedisinsk avdeling
Research Overview
- A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants with Moderately to Severely Active Ulcerative Colitis
- A Phase 3, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Multicenter Trial to Confirm the Efficacy and Safety of Glepaglutide 10 mg Twice-Weekly, Followed by a Long-Term, Open-Label Safety Evaluation in Patients with Short Bowel Syndrome–Intestinal Failure (SBS-IF)
Data & Insights
Has run more than one trial at 10 of 154 partner sites.
Specializations
Inflammatory Bowel Disease and Hepatobiliary Disorders
Marte Lie Høivik is involved in clinical research on Crohn’s disease, ulcerative colitis, and related gastrointestinal inflammation, with additional interest in primary sclerosing cholangitis and other hepatobiliary disease areas.
- Crohn’s disease
- Ulcerative colitis
- Primary sclerosing cholangitis
- Gastrointestinal inflammation
Her work also extends to therapeutic strategies that address chronic immune-mediated disease activity and long-term disease control in digestive disorders.
Gastrointestinal Oncology
Her research landscape includes gastrointestinal cancer, especially colorectal cancer, gastric cancer, gastroesophageal junction cancer, and hepatocellular carcinoma, with attention to advanced and recurrent disease settings.
- Colorectal cancer
- Gastric and gastroesophageal junction cancer
- Hepatocellular carcinoma
- Advanced solid tumours
She is also linked to studies of immunotherapy and targeted therapy in digestive tract malignancies.
Cardiovascular and Thrombotic Disease
Marte Lie Høivik is active in research on atrial fibrillation, aortic stenosis, coronary artery disease, and broader cardiovascular disease, including prevention of thromboembolic events and postoperative vascular complications.
- Atrial fibrillation
- Aortic stenosis
- Coronary artery disease
- Thrombotic risk management
Her clinical trial involvement also covers antithrombotic therapy and interventions aimed at reducing cardiovascular morbidity.
Neuroinflammatory and Neurological Conditions
Her clinical research includes multiple sclerosis, migraine, dementia with Lewy bodies, and other neurological disorders with inflammatory or degenerative features.
- Multiple sclerosis
- Migraine
- Dementia with Lewy bodies
- Neurological impairment
She is also connected to studies in neuroprotection and symptom-focused treatment development for chronic neurological disease.
Immune-Mediated and Rare Diseases
Marte Lie Høivik is involved in research on autoimmune disease, rare inflammatory disorders, and immune dysregulation, including systemic lupus erythematosus, primary immune thrombocytopenia, and systemic mastocytosis.
- Systemic lupus erythematosus
- Primary immune thrombocytopenia
- Systemic mastocytosis
- Rare immune-mediated disorders
Her portfolio also touches on precision medicine approaches for uncommon diseases with limited therapeutic options.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.